Your browser doesn't support javascript.
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
Jogalekar, Manasi P; Veerabathini, Anurag; Gangadaran, Prakash.
  • Jogalekar MP; Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Veerabathini A; Maxim Integrated Products Inc., Chandler, AZ 85225, USA.
  • Gangadaran P; Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.
Exp Biol Med (Maywood) ; 245(11): 964-969, 2020 06.
Article in English | MEDLINE | ID: covidwho-72254
ABSTRACT
IMPACT STATEMENT Early availability of the sequence, the genetic material of SARS-CoV-2 (the virus that causes COVID-19), has prompted efforts towards identifying a safe and effective vaccine in the current public health emergency. To that end, understanding the pathophysiology of disease is crucial for scientists around the world. Since conventional vaccine development and manufacturing may take several years, it is important to think about alternative strategies that we could use to mitigate imminent catastrophe. We hope that this article will open up new avenues and provide insights that could potentially save hundreds of lives affected by COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Exp Biol Med (Maywood) Journal subject: Biology / Physiology / Medicine Year: 2020 Document Type: Article Affiliation country: 1535370220920540

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Exp Biol Med (Maywood) Journal subject: Biology / Physiology / Medicine Year: 2020 Document Type: Article Affiliation country: 1535370220920540